Global Travel Vaccines Market:

According to IMARC Group’s latest report, titled “Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027” finds that the market reached a value of US$ 3.2 Billion in 2021. Vaccines, or immunizations, refer to affordable, effective, biologically formulated medications that are administered in the body of an  individual to provide protection against potential infections by stimulating the immune systems by producing antibodies. They aid in fragmenting microorganisms or pathogens to protect the consumer from ailments and preventing life-threatening diseases, including meningitis, tetanus, measles, polio, and hepatitis. On account of these properties, travelers visiting any region across the world can get the immunization shot before the journey to minimize microbial invasion and enhance overall health. At present, travel vaccinations are categorized into mono and combination immunization composition types.

Request for a PDF sample of this report: https://www.imarcgroup.com/travel-vaccines-market/requestsample

Travel Vaccines Market Trends:

The rapid expansion in the tourism industry, along with the increasing prevalence of various life-threatening infections and endemic diseases, such as coronavirus disease (COVID-19), due to the fueling number of international tourist arrivals from different nations, represents some of the prime factors driving the travel vaccine market growth. In line with this, favorable initiatives are being undertaken by the governments and several other regulatory bodies for investing in pharmaceutical companies to develop and supply vaccines. This, along with the implementation of various policies mandating the full vaccination of travelers prior visiting certain regions, are acting as other growth-inducing factors. Additionally, significant advancements, such as the introduction of messenger ribonucleic acid (mRNA) vaccines that correspond to the genetic sequence and helps the body make necessary infection-fighting proteins are contributing to the market growth.

This, in turn, increases protein translation, improves adaptive immunogenicity and delivery, and provides protection against life threatening diseases, while reducing the chances of developing serious consequences post vaccination. Moreover, strategic collaborations amongst key players and extensive funding in research and development (R&D) activities for engineering effective vaccines are propelling the market growth. Other factors, such as rising healthcare expenditure, increasing geriatric population that are more susceptible to developing various travel-related infectious diseases, and growing awareness amongst consumers regarding the availability of different vaccination programs, are creating a positive outlook for the market. Looking forward, IMARC Group expects the global travel vaccines market to reach US$ 6.6 Billion by 2027, exhibiting at a CAGR of 11.1% during 2022-2027.

Checkout Now: https://www.imarcgroup.com/checkout?id=1155&method=1

Competitive Landscape:

• GlaxoSmithKline Pharmaceuticals Limited
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• ALK-Abelló A/S
• Bavarian Nordic A/S
• Crucell (Subsidiary of Johnson & Johnson)
• CSL Limited
• AstraZeneca PLC
• Altimmune, Inc.
• Abbott Laboratories
• Hoffmann-La Roche, Inc.

Breakup by Composition:

• Mono Vaccines
• Combination Vaccines

Breakup by Disease:

• Hepatitis A
• DPT
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles and Mumps
• Rabies
• Meningococcal
• Varicella
• Japanese Encephalitis
• Others

Regional Insights:

• Asia Pacific
• North America
• Europe
• Middle East and Africa
• Latin America

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/travel-vaccines-market

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800